CompletedNCT06292481Updated Mar 5, 2024

Combine Effects of Brunnstorm Movement Therapy and LLLT in Chronic Stroke Patient

An interventional study of Brunnstorm movement therapy and Combined Brunnstorm Movement therapy and low level laser therapy in Chronic Stroke, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-05.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

Registered 5 months after the study started (first participant enrolled Aug 2023, registered Jan 2024).

Phase: Not applicable
Study type: Interventional
Enrollment: 48
Allocation: Randomized
Ages: 40 Years to 60 Years
Sex: All

Study summary

The primary objective of this study is to determine the combined effects of Brunnstorm movement therapy and low level laser therapy on upper limb function in chronic stroke patient.

Conditions studied

Chronic Stroke

Browse trials for

Stroke 7,286

Keywords

Brunnstorm movement therapy
Hand dexterity
Low-level laser therapy
Stroke

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 48 is close to the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 40 Years to 60 Years
Sexes eligible: All
Accepts healthy volunteers: Yes

Inclusion criteria

Age range between 40 \& 60 years (16)
Both males and females.
Combined Effects of Brunnstorm movement therapy and LLLT on Upper limb function Hand dexterity in stroke
Patient with maximum Grade 1 and 1+ spasticity according to Modified
Ashworth scale and minimum muscle strength of 1 in the biceps brachii muscle.
Onset of injury : (1 to 2 years)

Exclusion criteria

Exclusion Criteria:

Any comorbidity such as malignancy, inflammatory rheumatologic disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus erythematosus, etc.
Have a pacemaker or a history of serious cardiac events or of cardiorespiratory dysfunction.
Visual impairment
Any other musculoskeletal disorders of extremity
Severe cognitive impairment or aphasia leading to difficulty in communication, Participants unwilling to comply with the protocol.

Study design

Phase: Not applicable
Primary purpose: Treatment
Allocation: Randomized
Intervention model: Parallel assignment
Masking: Double (Participant, Investigator)
Enrollment: 48 participants (actual)

Study arms

Experimental
Brunnstorm Movement therapy
this group received Brunnstorm Movement therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks
Other: Brunnstorm movement therapy
Experimental
Combined Brunnstorm Movement therapy and low level laser therapy
this group received Combined Brunnstorm Movement therapy and low level laser therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks
Other: Combined Brunnstorm Movement therapy and low level laser therapy

Interventions

OtherBrunnstorm movement therapy
this group received Brunnstorm Movement therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks
OtherCombined Brunnstorm Movement therapy and low level laser therapy
this group received Combined Brunnstorm Movement therapy and low level laser therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks

What researchers measure

Primary outcomes

Fugle meyer Assessment test
Time frame: 6th week
Box and block test
Time frame: 6th week
Nine peg hole test
Time frame: 6th week
to check Muscle tone
Modified Ashworth Scale
Time frame: 6th week
to measure grip Strength
Hand handled dynamometer
Time frame: 6th week

Study locations

1 site

Govt. Mian Munshi DHQ Teaching hospital
Lahore, Punjab 54000, Pakistan

References and documents

Publications

das Neves MF, Aleixo DC, Mendes IS, Lima FPS, Nicolau RA, Arisawa EAL, Lopes-Martins RAB, Lima MO. Long-term analyses of spastic muscle behavior in chronic poststroke patients after near-infrared low-level laser therapy (808 nm): a double-blinded placebo-controlled clinical trial. Lasers Med Sci. 2020 Sep;35(7):1459-1467. doi: 10.1007/s10103-019-02920-3. Epub 2019 Dec 10. PubMed 31823135 ↗
da Silva BP, Souza GADS, Filho AADN, Pinto AP, Guimaraes CL, Pereira APC, Neves MFD, Martins PSLL, Lima FPS, Lopes-Martins RAB, Lima MO. Analysis of the effects of low-level laser therapy on muscle fatigue of the biceps brachii muscle of healthy individuals and spastic individuals: Study protocol for a single-center, randomized, double-blind, and controlled clinical trial. Medicine (Baltimore). 2019 Sep;98(39):e17166. doi: 10.1097/MD.0000000000017166. PubMed 31574822 ↗
Azuma RHE, Merlo JK, Jacinto JL, Borim JM, da Silva RA, Pacagnelli FL, Nunes JP, Ribeiro AS, Aguiar AF. Photobiomodulation Therapy at 808 nm Does Not Improve Biceps Brachii Performance to Exhaustion and Delayed-Onset Muscle Soreness in Young Adult Women: A Randomized, Controlled, Crossover Trial. Front Physiol. 2021 Jun 10;12:664582. doi: 10.3389/fphys.2021.664582. eCollection 2021. PubMed 34177615 ↗
Stamborowski SF, de Oliveira Spinelli BM, Lima FPS, Costa DR, de Silveira Souza GA, Lima MO, Lopes Martins RAB. The influence of photobiomodulation on the temperature of the brachial biceps during muscle fatigue protocol. Lasers Med Sci. 2021 Oct;36(8):1741-1749. doi: 10.1007/s10103-021-03360-8. Epub 2021 Jul 13. PubMed 34255219 ↗
Vassao PG, Baldini GS, Vieira KVSG, Balao AB, Pinfildi CE, Campos RMDS, Tucci HT, Renno ACM. Acute Photobiomodulation Effects Through a Cluster Device on Skeletal Muscle Fatigue of Biceps Brachii in Young and Healthy Males: A Randomized Double-Blind Session. Photobiomodul Photomed Laser Surg. 2020 Dec;38(12):773-779. doi: 10.1089/photob.2019.4786. PubMed 33332234 ↗
Harada T, Miyagi M, Izukura H, Endou G, Ushigome N, Tsuruoka H, Mizutani A, Ohshiro T, Ebihara S. The effect of low level laser therapy for pain in major muscles controlling two joints. Laser Ther. 2019 Jun 30;28(2):111-115. doi: 10.5978/islsm.19-OR-07. PubMed 32921909 ↗

Individual participant data

Plan to share: No

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Mar 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT06292481
Lead sponsor: Riphah International University
Responsible party: Sponsor
First posted: Mar 5, 2024
Start date: Aug 1, 2023
Primary completion: Sep 30, 2023
Completion: Oct 10, 2023
Last update: Mar 5, 2024

Study contacts

Binash Afzal, PHD*

principal investigator · Riphah international university lahore campus

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stroke→

Other studies from this sponsor

Riphah International University

Start the discussion